Using High-Throughput Automation to Accelerate Biologic Drug Formulation

Oct 25, 2018

Register Free: http://www.biopharminternational.com/bp_w/successes

Formulation development for proteins is an expensive, labor-intensive, and time-consuming process. As a result, the biopharma industry has largely adapted a strategy of custom-designed research programs for each new molecule. Given the unique nature of each molecule, can a high-throughput, platform research strategy accomplish the same goal of identifying an optimal formulation but in less time, with less effort, and with the same scientific validity and confidence?

This feat may be accomplished through intelligent study design, but  also depends heavily on high-throughput automation systems for sample preparation and analysis, as well as plate-based assays for analytical testing.

Learn in this Unchained Labs sponsored webcast how Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO), has implemented intelligent design and high-throughput processes to accelerate the development of a range of different molecules.

 

Key Learning Objectives: 

In this webcast, participants will learn:

  • The challenges of a platform formulation development research program
  • How high-throughput formulation development can only be accomplished by combining new, efficient technologies with intelligent study design
  • How high-throughput formulation development enables faster formulation selection

 

Who Should Attend:

  • Formulation scientists who are looking to streamline formulation screening, development, and characterization
  • Researchers seeking to automate buffer exchange, stability testing, forced degradation or stress testing processes
  • Scientists interested in advancements in automation tools, and practical approaches to protein formulation

 

Speakers:

Mark Spears Jr, PhD, Senior Scientist, Fujifilm Diosynth Biotechnologies

Donna Chen, Product Manager, Unchained Labs

 

Date and Time:

Live: Thursday, 25 October, 2018 at 11 am EDT | 8 am PDT | 1600 BST | 1700 CEST

After the final airing of the webcast on 25 October, 2018 it will be available on demand until 25 October, 2019. 

Sponsor: Unchained Labs

Register Free: http://www.biopharminternational.com/bp_w/successes

native1_300x100
lorem ipsum